PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29396886-0	2018	Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma.	Metformin	21-30	nuclear factor kappa B subunit 1	Homo sapiens	58-80	
29396886-7	2018	We found that localization of NF-kappaB in the nucleus was reduced after metformin treatment.	Metformin	73-82	nuclear factor kappa B subunit 1	Homo sapiens	30-39	
29396886-8	2018	This suggests that metformin inhibited the activation of NF-kappaB.	Metformin	19-28	nuclear factor kappa B subunit 1	Homo sapiens	57-66	
29396886-12	2018	In conclusion, metformin showed multiple antitumor effects such as growth suppression, invasion inhibition, and control of EMT by inhibiting NF-kappaB localization on ESCC.	Metformin	15-24	nuclear factor kappa B subunit 1	Homo sapiens	141-150